EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Lean Mass Gains, Cardiac Remodeling, and Muscle Oxidative Changes With High‐Dose Salbutamol During Resistance Training: A Randomized Controlled Trial

Morten Hostrup iD, Søren Jessen, Susanne Glasius Tischer, Anders Kalsen, Rakin Hadad, Philip Lykkebæk Bonde, Michael Kreiberg, Anders Schulze Gad, Ahmad Sajadieh, Vibeke Backer, Jens Bangsbo, Hanne Rasmusen

Scandinavian Journal of Medicine & Science in Sports · 2026

DOI: 10.1111/sms.70302 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Scandinavian Journal of Medicine & Science in Sports, 2026. Verfasst von Morten Hostrup und 11 weiteren Autor:innen. Beteiligte Einrichtung: Section of Integrative Physiology, University of Copenhagen, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Albuterol, Resistance Training, Adrenergic beta-2 Receptor Agonists, Ventricular Remodeling. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: World Anti-Doping Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Misuse of beta 2 ‐agonists to promote leanness is increasingly reported among young men undertaking resistance training. However, preclinical models demonstrate adverse cardiac remodeling with high‐dose beta 2 ‐agonist. We investigated effects of prolonged supratherapeutic treatment with salbutamol on body composition, cardiac morphology and function, and muscle oxidative phenotyping during resistance training. In a double‐blind, randomized trial, 30 healthy, trained men (age 23 ± 2 years, mean ± SD) received oral salbutamol 16 mg/day (SAL) or placebo (PLA) during an 11‐week, supervised full‐body resistance training program (3 sessions/week). Assessments at baseline and follow‐up included dual‐energy X‐ray absorptiometry, echocardiography, cardiac magnetic resonance imaging (CMR), cardiopulmonary exercise testing (CPET), and vastus lateralis biopsies. The primary outcome was change in lean mass. Twenty‐six participants completed the study. Lean mass increased 1.8 kg more in SAL than PLA (95% CI 0.5–3.1; p < 0.01). CMR showed no between‐group differences in cardiac structure or function, including left ventricular mass. Echocardiography showed increased posterior, septal, and relative wall thickness in SAL compared to PLA ( p < 0.01). Time to exhaustion during CPET did not change in SAL but increased by 7% in PLA ( p < 0.01). Muscle capillary density and citrate synthase and 3‐hydroxyacyl‐CoA dehydrogenase activity decreased in SAL (all p < 0.01), with no such changes in PLA. While supratherapeutic salbutamol augmented lean mass gains during resistance training, it concurrently impaired muscle oxidative capacity, attenuated cardiopulmonary fitness improvements, and showed echocardiographic signals consistent with increased wall thickness. These risk–benefit trade‐offs inform illicit users of potential harms and support restrictions on supratherapeutic salbutamol in sports.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlbuterolResistance TrainingAdrenergic beta-2 Receptor AgonistsVentricular RemodelingBody CompositionHeartQuadriceps MuscleHumansMaleYoung AdultDouble-Blind MethodAdultEchocardiographyExercise TestMagnetic Resonance ImagingAbsorptiometry, PhotonMuscle, Skeletal

Stichwörter der Autor:innen

adrenoceptorbeta‐2 agonistshearthypertrophymuscle

Substanzen

AlbuterolAdrenergic beta-2 Receptor Agonists

Autor:innen und Institutionen

  • Section of Integrative Physiology, University of Copenhagen, Copenhagen, Denmark.
  • Department of Clinical Physiology and Nuclear Medicine, Bispebjerg University Hospital, Copenhagen, Denmark.
  • Department of Cardiology, Copenhagen University Hospital, Amager og Hvidovre Hospital, Copenhagen, Denmark.
  • Department of Cardiology, Bispebjerg University Hospital, Copenhagen, Denmark.
  • Department of Otorhinolaryngology, Head & Neck Surgery, Rigshospitalet University Hospital, Copenhagen, Denmark.

ORCID-Profile: Morten Hostrup

Förderung

  • World Anti-Doping Agency

Zitieren

APA

Hostrup, M., Jessen, S., Tischer, S. G., Kalsen, A., Hadad, R., Bonde, P. L., Kreiberg, M., Gad, A. S., Sajadieh, A., Backer, V., Bangsbo, J., & Rasmusen, H. (2026). Lean Mass Gains, Cardiac Remodeling, and Muscle Oxidative Changes With High‐Dose Salbutamol During Resistance Training: A Randomized Controlled Trial. Scandinavian Journal of Medicine & Science in Sports. https://doi.org/10.1111/sms.70302

Vancouver

Hostrup M, Jessen S, Tischer SG, Kalsen A, Hadad R, Bonde PL, et al. Lean Mass Gains, Cardiac Remodeling, and Muscle Oxidative Changes With High‐Dose Salbutamol During Resistance Training: A Randomized Controlled Trial. Scandinavian Journal of Medicine & Science in Sports. 2026. doi:10.1111/sms.70302

BibTeX
@article{Hostrup2026,
  author = {Hostrup, Morten and Jessen, Søren and Tischer, Susanne Glasius and Kalsen, Anders and Hadad, Rakin and Bonde, Philip Lykkebæk and Kreiberg, Michael and Gad, Anders Schulze and Sajadieh, Ahmad and Backer, Vibeke and Bangsbo, Jens and Rasmusen, Hanne},
  title = {Lean Mass Gains, Cardiac Remodeling, and Muscle Oxidative Changes With High‐Dose Salbutamol During Resistance Training: A Randomized Controlled Trial},
  journal = {Scandinavian Journal of Medicine & Science in Sports},
  year = {2026},
  doi = {10.1111/sms.70302}
}
Kostenlos starten →